Delivery Order SPE2DB25D2204-SPE2DB25FTHAU
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $71K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $40,974.26 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication that represents part of the broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $3,437.98 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 18, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, aligning with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,344.41 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a branded pharmaceutical product used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $15,470.35 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units) with a completion date of September 9, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $44,369.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive award was performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used in the treatment of type 2 diabetes, and this delivery order represents one of many pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $17,494.75 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on July 9, 2025, with a completion date of July 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Mounjaro is a diabetes treatment medication, consistent with AmerisourceBergen's role as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $19,551.08 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, reflecting the contractor's established...
- The Defense Logistics Agency awarded a $9,557.22 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens (0.5 ml) with an ultimate completion date of September 16, 2025. This is a firm fixed price contract with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,681.38 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on August 29, 2025, with completion expected by September 2, 2025. This competitively awarded, firm fixed-price delivery order requires fulfillment at AmerisourceBergen's Conshohocken, Pennsylvania location and represents no set-aside designation. Mounjaro is a prescription medication used for diabetes management, consistent with AmerisourceBergen's role...